Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
| Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and Boehringer Ingelheim Pharmaceuticals Inc. |
| Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited |
| 1:2020cv00019 |
| February 5, 2020 |
| US District Court for the Northern District of West Virginia |
| Irene M Keeley |
| Patent |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 8, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 32
ORDER granting #31 Motion to Withdraw of Atty. Leora Ben-Ami as counsel for Plaintiffs. Signed by Senior Judge Irene M. Keeley on 4/2/20. (jss)
|
|
Filing 31
MOTION to Withdraw of Atty. Leora Ben-Ami as counsel for Plaintiffs by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Companion, James)
|
|
Filing 30
Pro Hac Vice Filing fees for D. Mukerjee, L. Soderstrom and J. Janusz: $ 600.00, receipt number WVNC002874 (jss)
|
|
Filing 29
ORDER granting Lance A. Soderstrom's #24 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 3/4/20. (jss)
|
|
Filing 28
ORDER granting Deepro R. Mukerjee's #25 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 3/4/20. (jss)
|
|
Filing 27
ORDER granting Joseph M. Janusz's #26 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 3/4/20. (jss)
|
|
Filing 26
MOTION for Leave to Appear Pro Hac Vice (Joseph M. Janusz) by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William)
|
|
Filing 25
MOTION for Leave to Appear Pro Hac Vice (Deepro R. Mukerjee) by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William)
|
|
Filing 24
MOTION for Leave to Appear Pro Hac Vice (Lance A. Soderstrom) by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(O'Brien, William)
|
|
Filing 23
STIPULATION REGARDING RESPONSIVE PLEADING DEADLINE (APRIL 12, 2020) by Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc.. (O'Brien, William)
|
|
Filing 22
WAIVER OF SERVICE Returned Executed by Mylan Laboratories Limited. Mylan Laboratories Limited waiver sent on 2/12/2020, answer due 4/13/2020. (O'Brien, William)
|
|
Filing 21
SUMMONS Returned Executed as to Mylan Inc. service accepted by SOS on 2/6/2020. (jss)
|
|
Filing 20
SUMMONS Returned Executed as to Mylan Pharmaceuticals Inc. service accepted by SOS on 2/6/2020. (jss)
|
|
Filing 19
ORDER granting Jeanna Wacker's #13 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 2/13/20. (jss)
|
|
Filing 18
ORDER granting Mira Mulvaney's #12 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 2/13/20. (jss)
|
|
Filing 17
ORDER granting Leona Ben-Ami's #11 Motion for Leave to Appear pro hac vice. Signed by Senior Judge Irene M. Keeley on 2/13/20. (jss)
|
|
Filing 16
ORDER: It is ORDERED that the Court GRANTS Plaintiffs' #14 Motion for Leave to Withdraw as Counsel. Attorneys Sam Kwon, Ashley Ross, Christopher J. Citro and Thomas F. Fleming terminated. Signed by Senior Judge Irene M. Keeley on 2/13/2020. (cnd)
|
|
Filing 15
Pro Hac Vice fees for Leora Ben-Ami, Mira Mulvaney, and Jeanna Wacker: $ 600.00, receipt number WVNC002861. (cnd)
|
|
Filing 14
MOTION to Withdraw as Counsel of Attorneys Thomas F. Fleming, Sam Kwon, Ashley Ross and Christopher J. Citro by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Companion, James)
|
|
Filing 13
MOTION for Leave to Appear Pro Hac Vice of Jeanna Wacker by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Companion, James)
|
|
Filing 12
MOTION for Leave to Appear Pro Hac Vice of Mira Mulvaney by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Companion, James)
|
|
Filing 11
MOTION for Leave to Appear Pro Hac Vice of Leora Ben-Ami by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Proposed Order)(Companion, James)
|
|
Filing 10
ORDER -- FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 3/30/2020. Rule 26 Meeting Report due by 4/13/2020. Scheduling Conference set for 4/27/2020 at 01:00 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Discovery due by 5/4/2020. Signed by Senior Judge Irene M. Keeley on 2/12/20. (jss)
|
|
Filing 9
NOTICE of Appearance by William J O'Brien on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. (O'Brien, William)
|
|
Filing 8
VERIFICATION OF ATTORNEY ADMISSION as to L. Ben-Ami, T. Fleming, J. Wacker, M. Mulvaney, S. Kwon, A. Ross and C. Citro. (jss)
|
|
Filing 5
Filing fee: $ 400.00, receipt number WVNW002384 (jss)
|
|
Filing 4
REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jss)
|
|
Filing 3
Corporate Disclosure Statement. (jss)
|
|
Filing 2
Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (jss)
|
|
Filing 1
COMPLAINT against Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Attachments: #1 Exhibit 1 - Patent Appplication Publication, #2 Civil Cover Sheet)(jss)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
